Indications
Lumark is a radiopharmaceutical precursor. It is not intended for direct use in patients. This medicinal must be used only for the radiolabelling of carrier molecules, which have been specifically developed and authorised for radiolabelling with this radionuclide.
Composition
- Active substance
- lutetium (177Lu) chloride
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Lumark
- Active substance
- lutetium (177Lu) chloride
- ATC code
- V10
- Group
- Various
- Therapeutic area
- Radionuclide Imaging
- Marketing authorisation holder
- I.D.B. Radiopharmacy B.V.
- Status
- Withdrawn